Impact of Early Automated Insulin Delivery on Glycemia Over Two Years

A 104-week observational extension of a randomized clinical trial involving 61 youth with recent type 1 diabetes diagnosis. The dataset includes secondary analysis of continuous glucose monitoring (CGM) data, comparing time in range (TIR) and hemoglobin A1c between intensive care and standard care groups. The supplementary material was authored by figshare admin karger and last updated in June 2026.

Use Cases

• Analyze the persistence of glycemic control based on time in range (TIR) data over a two-year period.
• Compare hemoglobin A1c outcomes between different diabetes management protocols described in the trial.
• Study the adoption and discontinuation rates of automated insulin delivery (AID) systems in a clinical setting.
• Investigate the relationship between early intensive management and long-term glycemic stability mentioned in the results.

Strengths

• Data originates from a structured clinical trial with a randomized control group, providing a basis for comparative analysis.
• Includes specific, reported metrics such as mean time in range (65% to 79%) and mean hemoglobin A1c (6.7% to 7.2%).
• Tracks participant outcomes over a defined 104-week (two-year) period post-diagnosis.

Limitations

• Row count is unknown, which may limit suitability assessment.
• Column-level documentation is absent; field semantics must be inferred after download.
• The dataset is very small (70.7 KB), indicating limited scope, likely containing summary results or documentation rather than raw patient-level data.

Provenance

Source

figshare

Collection Method

Secondary analysis of a randomized clinical trial and its observational extension phase.

Time Range

104 weeks post-type 1 diabetes diagnosis.

Freshness

Last updated 2026-06-03 05:55:17; freshness should be verified.